Commence™ and The Language Group Launch Fetch, a Patent-Pending Translation Solution, to Improve Patient Outcomes
Fetch integrates real-time, AI-powered, human-reviewed translation into Electronic Health Record (EHR) systems, saving millions in preventable costs and improving care for non-English-speaking patients.
VIRGINIA BEACH, Va. --(BUSINESS WIRE)
Today, Commence together with The Language Group (TLG) announced the launch of Fetch, a first-of-its-kind, patent-pending solution that delivers real-time, AI-powered, human-reviewed translations of patient discharge instructions directly within electronic health record (EHR) systems.
Designed for rapid scaling across commercial health environments, this solution addresses a critical gap in healthcare communication: enabling patients with limited English proficiency (LEP) to leave the hospital with clear, accurate, and understandable instructions in their preferred language. By automating translation and embedding it into standard discharge workflows, the solution improves patient understanding, reduces costly readmissions, and supports compliance with federal requirements.
“Language access shouldn’t be a paperwork burden—it should be a strategic advantage,” said Alex Payne, Vice President of Sales at Commence. “Our solution turns complex translation workflows into streamlined, measurable, and scalable operations that help hospitals deliver care patients understand.”
Solving a Costly and Widespread Challenge
One large integrated health system serving 150-200 limited-English proficient (LEP) patients per day estimated readmissions among patients discharged without translated instructions at 14% with an average cost of $15,200 per readmission. A system of this size could expect to save more than $4.6 million annually with Fetch.
Commence's Translation Solution, Fetch, Delivers
- Patent-pending, AI-powered translation with human review
- Seamless integration with EHR platforms, including Epic
- Epic Showroom approval and listing
- Delivery of discharge instructions in minutes
- Unified dashboards for utilization, compliance, and cost tracking
The solution is built to meet the highest standards for patient safety and regulatory compliance, including -
- Section 1557 of the Affordable Care Act
- Title VI and CLAS standards
- Joint Commission requirements
- HIPAA and SOC 2 Type II compliance
- ISO 18587 certified
For decades, providers have relied on fragmented, manual translation workflows to meet language needs—often hours or days after the point of care. Commence changes that. By combining AI-powered translation with clinical review, the platform enables hospitals to deliver accurate, timely, and understandable care instructions before a patient even leaves the room.
The solution fits seamlessly into existing discharge workflows, eliminating delays, reducing risk, and improving outcomes for diverse patient populations.
About Commence
Commence creates data-centered healthcare solutions that deliver measurable outcomes across federal, state, and commercial markets. By combining clinical expertise, innovative technology, and real-world data, Commence helps agencies and providers streamline operations, improve care quality, and reduce risk across complex health programs.
Headquartered in Virginia Beach, Commence supports over 200 clients nationwide and serves 60% of the Medicare population. Whether accelerating reviews, reducing costs, or transforming workflows, Commence empowers health organizations to perform beyond the scope with clarity and compassion.
Learn more at commence.ai.
About The Language Group
The Language Group (TLG) is a trusted provider of professional language solutions, specializing in translation, localization, and interpretation services. With ISO 17100 and ISO 18587 certifications, TLG delivers high-quality, technology-driven language services to industries including healthcare, legal, and corporate enterprises.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250918294979/en/
[email protected]
757.306.4920.
Copyright Business Wire 2025
Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]